The FDA initially refused to review Moderna’s application for a new mRNA flu shot, sparking controversy over regulatory inconsistency and political influence, but reversed course after high-level intervention. The episode reveals deep turmoil at the agency under the Trump administration,
Sign up to read the full summary
Free AI-powered recaps of every episode, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.
Guest
Liz Esley-White
interview on The Journal.
Mentions
Books, people, and resources mentioned in this episode.
People
Companies
Topics
Listen to This Episode
More from The Journal.
The Vape Cloud Hanging Over the FDA
The Cancer Vaccine That Could Save Moderna
What's Going On With Lettuce?
Novo Nordisk's CEO Has a Comeback Plan
How Big Food Is Navigating the GLP-1 Era
Weight-Loss Drugs Are Gobbling Up Small Town Budgets
Related episodes
From other shows on similar topics.
The Global Story: Will the new cancer vaccine survive RFK Jr’s America?
Global News Podcast
The Munich Security Conference; FDA Rejects Flu Vaccine; The Fall of The Quad God
Up First from NPR
Trump Top Pick Falls Apart Under Cross Exam at Hearing
The MeidasTouch Podcast
A New Plan for Closer U.S.-Israel Military Cooperation, and the First mRNA Flu Vaccine
The Headlines
How a single flu shot could protect you for decades
Short Wave
Episode 208: Bad News, Good News
Osterholm Update
Get summaries like this every morning.
Free AI-powered recaps of The Journal. and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.